The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effects of regorafenib (REG) therapy on health-related quality of life (HRQoL) in patients with metastatic colorectal cancer (mCRC) in the phase III CONCUR trial.
 
Jane Chang
Employment - Bayer
Stock and Other Ownership Interests - Bayer
Travel, Accommodations, Expenses - Bayer
 
Christopher Ngai
Employment - Bayer
Stock and Other Ownership Interests - Pfizer
 
Dawn Odom
Other Relationship - Rho (I); RTI Health Solutions
 
Christina Radder
No Relationships to Disclose
 
Christian Kappeler
Employment - Bayer Schering Pharma
Stock and Other Ownership Interests - Bayer Schering Pharma
 
Rui-hua Xu
No Relationships to Disclose
 
Shukui Qin
No Relationships to Disclose
 
Tae Won Kim
Honoraria - Bayer
Consulting or Advisory Role - Abbvie; Lilly
Research Funding - Bayer (Inst)
 
Jin Li
Research Funding - Merck